glutathione and triple negative breast cancer Frontiers Glutathione-depleting self-immolative nanoparticles boost cuproptosis-driven
Glutathione depleting self immolative nanoparticles boost cuproptosis driven metalloimmunotherapy for triple negative breast cancer Journal of Nanobiotechnology Springer Nature Link Oncology Letters GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect Heterogeneity and transcriptional drivers of triple negative breast cancer: Cell Reports
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



